| 21.41 Data as of Jun 18 |  +0.35 / +1.66%Today’s Change | 15.43 Today|||52-Week Range 26.30 | +28.90% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Hastings David C Chief Financial Officer |  Sale | 2/15/2013 | 100,000 | $22.52 | $2.3M | -2.68% |
Swain Paula J EVP-Human Resources | Sale | 2/20/2013 | 103,283 | $21.53 | $2.2M | +0.99% |
Levy Richard S Chief Drug Development & Medical Officer & EVP | Sale | 2/15/2013 | 98,440 | $22.48 | $2.2M | -2.68% |
Levy Richard S Chief Drug Development & Medical Officer & EVP | Sale | 5/13/2013 | 55,699 | $22.30 | $1.2M | -10.38% |
Siegel Eric H General Counsel & EVP | Sale | 2/28/2013 | 50,000 | $22.16 | $1.1M | -3.69% |
Whitfield Roy A Director | Sale | 5/17/2013 | 40,000 | $23.08 | $923.2K | -7.07% |
Chardonnet Laurent | Sale | 7/02/2012 | 36,666 | $24.15 | $885.5K | -13.81% |
De Schutter Richard U Director | Sale | 12/17/2012 | 50,000 | $16.03 | $801.5K | +33.35% |
De Schutter Richard U Director |  Buy | 12/17/2012 | 45,000 | $16.11 | $725.0K | +33.35% |
Chardonnet Laurent | Sale | 7/05/2012 | 27,300 | $25.11 | $685.5K | -14.87% |
.
